Log in

NASDAQ:CHNGChange Healthcare Insider Trades

-0.12 (-1.13 %)
(As of 07/9/2020 04:00 PM ET)
Today's Range
Now: $10.47
50-Day Range
MA: $11.75
52-Week Range
Now: $10.47
Volume1.78 million shs
Average Volume6.27 million shs
Market Capitalization$3.18 billion
P/E Ratio261.82
Dividend YieldN/A

Insider Trades

Change Healthcare (NASDAQ:CHNG) Insider Buying and Selling Activity

Insider Ownership Percentage: 20.77%

Insider Buying and Selling by Quarter

Change Healthcare (NASDAQ CHNG) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/10/2020Fredrik J. EliassonCFOBuy100,000$12.00$1,200,000.00  
8/15/2019Crescenzo Neil E DeCEOBuy75,000$14.17$1,062,750.00  
8/15/2019Fredrik J EliassonCFOBuy40,000$13.73$549,200.00  
7/1/2019August CalhounInsiderBuy1,000$13.00$13,000.00  
7/1/2019Bansi NagjiDirectorBuy5,000$13.00$65,000.00  
7/1/2019Fredrik J EliassonCFOBuy30,000$13.00$390,000.00  
6/28/2019August CalhounInsiderBuy427,209$13.35$5,703,240.15
(Data available from 1/1/2013 forward)
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.